KNSA logo

Kiniksa Pharmaceuticals (KNSA) Total debt

Annual Total Debt:

$9.86M-$2.40M(-19.60%)
December 31, 2024

Summary

  • As of today (May 29, 2025), KNSA annual total debt is $9.86 million, with the most recent change of -$2.40 million (-19.60%) on December 31, 2024.
  • During the last 3 years, KNSA annual total debt has risen by +$3.81 million (+62.89%).
  • KNSA annual total debt is now -19.60% below its all-time high of $12.26 million, reached on December 31, 2023.

Performance

KNSA Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAbalance sheet metrics

Quarterly Total Debt:

$9.91M+$60.00K(+0.61%)
March 31, 2025

Summary

  • As of today (May 29, 2025), KNSA quarterly total debt is $9.91 million, with the most recent change of +$60.00 thousand (+0.61%) on March 31, 2025.
  • Over the past year, KNSA quarterly total debt has dropped by -$2.23 million (-18.35%).
  • KNSA quarterly total debt is now -26.67% below its all-time high of $13.52 million, reached on June 30, 2023.

Performance

KNSA Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

KNSA Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.6%-18.4%
3 y3 years+62.9%+83.4%
5 y5 years+271.6%+342.6%

KNSA Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-19.6%+66.5%-26.7%+114.9%
5 y5-year-19.6%+271.6%-26.7%+540.9%
alltimeall time-19.6%>+9999.0%-26.7%>+9999.0%

KNSA Total debt History

DateAnnualQuarterly
Mar 2025
-
$9.91M(+0.6%)
Dec 2024
$9.86M(-19.6%)
$9.86M(-7.0%)
Sep 2024
-
$10.60M(-7.1%)
Jun 2024
-
$11.40M(-6.1%)
Mar 2024
-
$12.14M(-0.9%)
Dec 2023
$12.26M(+107.1%)
$12.26M(-5.4%)
Sep 2023
-
$12.96M(-4.1%)
Jun 2023
-
$13.52M(+140.8%)
Mar 2023
-
$5.62M(-5.1%)
Dec 2022
$5.92M(-2.2%)
$5.92M(-11.8%)
Sep 2022
-
$6.71M(+45.4%)
Jun 2022
-
$4.61M(-14.7%)
Mar 2022
-
$5.41M(-10.6%)
Dec 2021
$6.05M(-13.4%)
$6.05M(-10.3%)
Sep 2021
-
$6.75M(+9.9%)
Jun 2021
-
$6.14M(-6.7%)
Mar 2021
-
$6.57M(-5.9%)
DateAnnualQuarterly
Dec 2020
$6.99M(+163.4%)
$6.99M(+351.5%)
Sep 2020
-
$1.55M(-15.0%)
Jun 2020
-
$1.82M(-18.8%)
Mar 2020
-
$2.24M(-15.5%)
Dec 2019
$2.65M(>+9900.0%)
$2.65M(-11.6%)
Sep 2019
-
$3.00M(-9.5%)
Jun 2019
-
$3.31M(-8.5%)
Mar 2019
-
$3.62M(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
Dec 2017
$0.00(0.0%)
$0.00(0.0%)
Sep 2017
-
$0.00(0.0%)
Jun 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00
Dec 2016
$0.00
-

FAQ

  • What is Kiniksa Pharmaceuticals annual total debt?
  • What is the all time high annual total debt for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual total debt year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly total debt?
  • What is the all time high quarterly total debt for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly total debt year-on-year change?

What is Kiniksa Pharmaceuticals annual total debt?

The current annual total debt of KNSA is $9.86M

What is the all time high annual total debt for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual total debt is $12.26M

What is Kiniksa Pharmaceuticals annual total debt year-on-year change?

Over the past year, KNSA annual total debt has changed by -$2.40M (-19.60%)

What is Kiniksa Pharmaceuticals quarterly total debt?

The current quarterly total debt of KNSA is $9.91M

What is the all time high quarterly total debt for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly total debt is $13.52M

What is Kiniksa Pharmaceuticals quarterly total debt year-on-year change?

Over the past year, KNSA quarterly total debt has changed by -$2.23M (-18.35%)
On this page